Back
Speaker illustration

Professor Lazar Velicki

Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia)

Presentations

In silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy – SILICOFCM.

Event: Digital Health 2019

Topic: Big Data

Session: Data Analysis

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources